Blood transfusions are indicated for some acute complications of sickle cell disease (SCD). To characterize the SCD population at increased risk of transfusion-associated complications, Georgia hospital discharge data were used to estimate the frequency of intermittent transfusions and the proportion of patients receiving them at multiple institutions. Ten years of data (2007-2016) showed almost 19% of patients with SCD (1585/8529) received transfusions at more than one hospital. The likelihood of multisite transfusions increased from ages 18 through 40 and with the number of transfusions received. The results support the need to track and share transfusion histories in order to reduce complication risks.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27921DOI Listing

Publication Analysis

Top Keywords

intermittent transfusions
8
sickle cell
8
cell disease
8
transfusions
6
characterizing complication
4
complication risk
4
risk multisite
4
multisite intermittent
4
transfusions treatment
4
treatment sickle
4

Similar Publications

Zandelisib, a selective, potent PI3Kδ inhibitor, demonstrated favourable outcomes in patients with relapsed or refractory follicular lymphoma in a global phase II study. This phase II study evaluated the efficacy and safety of zandelisib for relapsed or refractory follicular lymphoma or marginal zone lymphoma. Sixty-one patients received zandelisib orally at 60 mg daily continuously in the first two 28-day cycles, followed by intermittent dosing on Days 1-7 following each cycle until progressive disease or unacceptable toxicity.

View Article and Find Full Text PDF

Background: Obesity and related metabolic disorders have reached epidemic levels, calling for diverse therapeutic strategies. Altering nutrient intake, timing and quantity by intermittent fasting seems to elicit beneficial health effects by modulating endocrine and cell signaling networks. This study explores the impact of cyclic nutrient availability in the form of every-other-day fasting (EODF) on human adipose stem cells (ASCs).

View Article and Find Full Text PDF

Here, we describe two cases of retained products of conception (RPOC) that were successfully managed with hysteroscopic resection after laparoscopic temporary uterine artery ligation. Both patients were diagnosed with RPOC after early miscarriages. Case 1 was urgently admitted due to massive bleeding and underwent surgery following a blood transfusion.

View Article and Find Full Text PDF

The development of alloantibodies or autoantibodies is a complication observed in sickle cell disease. Autoimmunization occurs in 7.6-12% of chronically or intermittently transfused patients with sickle cell disease; however, the clinical implications of autoAbs are unclear.

View Article and Find Full Text PDF

[AQUABLATION OF THE PROSTATE - A NOVEL ROBOTIC PROCEDURE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA].

Harefuah

July 2024

Department of Urology, Chaim Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Article Synopsis
  • Aquablation is a new robotic-assisted procedure using ultrasound and water jets to treat benign prostatic hyperplasia (BPH), aiming to assess its efficiency and safety.
  • A retrospective analysis of 50 patients revealed successful surgeries with no intra-operative complications, a median surgery time of 51 minutes, and minimal change in hemoglobin levels.
  • The procedure led to a significant improvement in urinary symptoms and quality of life, with most patients showing stable functional outcomes and none reporting significant urinary incontinence post-surgery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!